January 7, 2003
Draft proposal for a compromise solution, which should take the form of a footnote to
the draft prtosal of 16 December 2002
1 (a) "pharmaceutical product" means any patented product, or product
manuactured through a patented process, of the pharmaceutical
sector needed
to address the public health problems as recognised in paragraph 1
of the
Declaration (1). It is understood that active ingredients necessary
for its
manufacture and diagnostic kits needed for its use would be included;
(1) This covers at least HIV/AIDS, malaria, tuberculosis,
yellow fever, plague,
cholera, meningococcal disease, African trypanosomiasis, dengue,
influenza,
leishmaniasis, hepatitis, leptospirosis, pertussis, poliomyelitis,
schistosomiasis, typhoid fever, typhus, measles, shigellosis,
haemorrhagic
fevers and arboviruses. When requested by a Member, the World Health
Organization shall give its advice as to the occurrence in an
importing
Member, or the likelihood thereof, of any other public health
problem
Return to: CPTech Home -> Main IP Page -> CPTech Page on WTO -> Paragraph Six Page -> Scope of Diseases Page |